PRF Technologies Ltd. (PRFX)
PRFXNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$0.7968
-0.0145 (-1.79%) today
At the close, Nov 10, 4:00 PM ET. After hours $0.8100 +1.66%
- Market cap
- $2.79m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.7400 to $0.8100
- 52-week range
- $0.6410 to $7.95
- Average volume
- 267.4k
- Previous close
- $0.8113
Financials
No quarterly figures from the source.
News
7 latest- PainReform Ltd. Reports Preliminary $11.0 Million Cash Position and Outlines Strategic Initiatives for LayerBio and GridFeedFintel · Oct 23, 2026
- PainReform's Corporate Name Changes To PRF Technologies To Reflect Expansion; Stock Up RTTNews · Jan 16, 2026
- Top Stocks To Watch: IOVA Soars On Regulatory Approval, FDA Fast Tracks Aldeyra's Drug RTTNews · Aug 19, 2025
- PainReform Ltd. Launches Strategic Pilot Program with Econergy Renewable Energy Ltd. to Optimize Solar Energy Production using DeepSolar™ PlatformQuiver Quantitative · May 7, 2025
- PainReform Ltd. Completes Acquisition of DeepSolar, Expanding into Clean Energy SectorQuiver Quantitative · Mar 5, 2025
- PainReform Ltd. Acquires DeepSolar to Expand into Solar Analytics MarketQuiver Quantitative · Feb 18, 2025
- PainReform Ltd. Gains $3.17 Million from Warrant ExerciseTipRanks · Jan 2, 2025
The company
PRF Technologies (Nasdaq: PRFX) is a company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company's pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide prolonged post-surgical pain relief while minimizing the need for repeated dosing and reducing reliance on opioids. Through DeepSolar and GridFeed, PRF also develops advanced software solutions that enable both consumers and enterprises to monitor, forecast, trade and optimize energy - particularly in solar-integrated environments. This dual business model reflects PRF's strategic commitment to applying precision technology across high-impact sectors including healthcare and sustainable energy.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- Middle East
- Website
- painreform.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.